Amedica is to release its Valeo II C interbody fusion device system.
Here are five highlights:
1. The second generation cervical system will be commercially available mid-February 2016.
2. The Valeo II C interbody fusion device is made entirely of Amedica's micro-composite silicon nitride biomaterial and offers a slim-profile design which improves intraoperative visibility for more exact placement and postoperative visibility.
3. The new design also includes directional teeth to resist expulsion, an anterior thread connection for improved inserter stability and a 14x12mm footprint size for smaller patients.
4. The Valeo C family of products is the first to receive FDA clearance for two-level cervical interbody cage indications. Valeo cervical fusion devices are indicated for use in skeletally mature patients with degenerative disc disease at one disc level or two contiguous levels and are designed for use with autograft or allograft to facilitate fusion.
5. Amedica develops and commercializes silicon nitride ceramics as a biomaterial platform.